TXG (10x Genomics) Inventory Turnover: 0.81 (As of Mar. 2026)


TXG 10x Genomics Inc TXG
62 GF Score
Price $39.01
GF Value $18.97
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is 10x Genomics Inventory Turnover?

10x Genomics TXG -0.12% 62 Inventory Turnover is 0.81 as of Mar. 2026. GuruFocus rates TXG with a GF Score™ of 62/100 and a GF Value™ of $18.97 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. 10x Genomics's Cost of Goods Sold for the three months ended in Mar. 2026 was $44.7 Mil. 10x Genomics's Average Total Inventories for the quarter that ended in Mar. 2026 was $54.9 Mil. 10x Genomics's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.81.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. 10x Genomics's Days Inventory for the three months ended in Mar. 2026 was 112.19.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. 10x Genomics's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.36.

10x Genomics  (NAS:TXG) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

10x Genomics's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory =Average Total Inventories (Q: Mar. 2026 )/Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=54.914/44.665*365 / 4
=112.19

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

10x Genomics's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=54.914 / 150.843
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

10x Genomics Inventory Turnover Related Terms

10x Genomics Inventory Turnover Historical Data

* Premium members only.

The historical data trend for 10x Genomics's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

10x Genomics Inventory Turnover Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only 1.65 1.70 2.70 2.50 2.85

10x Genomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.67 0.74 0.90 0.81
TXG
62GF Score
10x Genomics Inc TXG
Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

10x Genomics Inventory Turnover Calculation

10x Genomics's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Inventory Turnover (A: Dec. 2025 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2025 ) / ((Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count )
=198.942 / ((83.107 + 56.341) / 2 )
=198.942 / 69.724
=2.85

10x Genomics's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover (Q: Mar. 2026 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Mar. 2026 ) / ((Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count )
=44.665 / ((56.341 + 53.487) / 2 )
=44.665 / 54.914
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Inventory Turnover →
What does a Inventory Turnover of 0.81 mean?
10x Genomics (TXG) has a Inventory Turnover of 0.81 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on 10x Genomics and its competitors.
Is 10x Genomics' Inventory Turnover too high?
10x Genomics' current Inventory Turnover is 0.81. Overall, 10x Genomics has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 10x Genomics' Inventory Turnover compare to DOCS and WAY?
10x Genomics' Inventory Turnover of 0.81 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory Turnover for a Healthcare Providers & Services company?
A good Inventory Turnover depends on the Healthcare Providers & Services industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory Turnover mean?
A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on 10x Genomics and its competitors. 10x Genomics's current Inventory Turnover is 0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 10x Genomics stock overvalued right now?
Based on GuruFocus' analysis, 10x Genomics (TXG) is currently considered Significantly Overvalued. The stock's GF Value™ is $18.97, compared to a current price of $39.01 — trading 105.6% above its estimated fair value. The current Inventory Turnover is 0.81. 10x Genomics' overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory Turnover calculated?
Inventory Turnover is calculated from a company's financial statements. For 10x Genomics (TXG), the current Inventory Turnover is 0.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 10x Genomics (TXG) Overvalued in 2026?

Based on GuruFocus' analysis, 10x Genomics stock appears to be overvalued. The current stock price of $39.01 is trading 105.6% above its estimated GF Value™ of $18.97. GuruFocus considers 10x Genomics to be Significantly Overvalued.

Key valuation signals for TXG:

  • Inventory Turnover: 0.81
  • GF Value™: $18.97 vs. price of $39.01 (105.6% above fair value)
  • GF Score™: 62/100 with 8 warning signs

No single metric tells the full story. See the TXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

10x Genomics Business Description

Other Exchanges 0A88:UK1KJ:Germany
Address 6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
62GF Score

Get the complete analysis for TXG

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$39.01
Price
$18.97
GF Value